663 related articles for article (PubMed ID: 19264885)
1. Cysteine-rich 61, a member of the CCN family, as a factor involved in the pathogenesis of proliferative diabetic retinopathy.
You JJ; Yang CH; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3447-55. PubMed ID: 19264885
[TBL] [Abstract][Full Text] [Related]
2. Cysteine-rich 61 (CYR61) is up-regulated in proliferative diabetic retinopathy.
Zhang X; Yu W; Dong F
Graefes Arch Clin Exp Ophthalmol; 2012 May; 250(5):661-8. PubMed ID: 22160564
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.
You JJ; Yang CH; Huang JS; Chen MS; Yang CM
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5290-8. PubMed ID: 17962485
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Cyr61/CCN1 expression by hypoxia through cooperation of c-Jun/AP-1 and HIF-1α in retinal vascular endothelial cells.
You JJ; Yang CM; Chen MS; Yang CH
Exp Eye Res; 2010 Dec; 91(6):825-36. PubMed ID: 21029732
[TBL] [Abstract][Full Text] [Related]
5. CCN1/Cyr61-PI3K/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy.
Di Y; Zhang Y; Nie Q; Chen X
Int J Mol Med; 2015 Dec; 36(6):1507-18. PubMed ID: 26459773
[TBL] [Abstract][Full Text] [Related]
6. Association of 150-kDa oxygen-regulated protein with vascular endothelial growth factor in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Alam K; Bittoun E; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2018 Jun; 96(4):e460-e467. PubMed ID: 29098793
[TBL] [Abstract][Full Text] [Related]
7. Elevation of angiogenic factor Cysteine-rich 61 levels in vitreous of patients with proliferative diabetic retinopathy.
You JJ; Yang CM; Chen MS; Yang CH
Retina; 2012 Jan; 32(1):103-11. PubMed ID: 21822163
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
[TBL] [Abstract][Full Text] [Related]
10. Osteoprotegerin Is a New Regulator of Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.
Abu El-Asrar AM; Struyf S; Mohammad G; Gouwy M; Rytinx P; Siddiquei MM; Hernández C; Alam K; Mousa A; De Hertogh G; Opdenakker G; Simó R
Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):3189-3201. PubMed ID: 28654984
[TBL] [Abstract][Full Text] [Related]
11. [Promoting effects of CYR61 on proliferation, migration and tube formation of choroid-retinal endothelial cells].
Zhang X; Yu WH; Dong FT
Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):619-24. PubMed ID: 22943867
[TBL] [Abstract][Full Text] [Related]
12. Suppressed expression of tubedown-1 in retinal neovascularization of proliferative diabetic retinopathy.
Gendron RL; Good WV; Adams LC; Paradis H
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3000-7. PubMed ID: 11687548
[TBL] [Abstract][Full Text] [Related]
13. Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis.
Zhou L; Zhang T; Lu B; Yu Z; Mei X; Abulizi P; Ji L
J Ethnopharmacol; 2016 Aug; 189():117-25. PubMed ID: 27196298
[TBL] [Abstract][Full Text] [Related]
14. Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy.
Kobayashi Y; Yoshida S; Zhou Y; Nakama T; Ishikawa K; Arima M; Nakao S; Sassa Y; Takeda A; Hisatomi T; Ikeda Y; Matsuda A; Sonoda KH; Ishibashi T
Mol Vis; 2016; 22():436-45. PubMed ID: 27186070
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
16. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
[TBL] [Abstract][Full Text] [Related]
17. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
18. Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization.
Al-Shabrawey M; Mussell R; Kahook K; Tawfik A; Eladl M; Sarthy V; Nussbaum J; El-Marakby A; Park SY; Gurel Z; Sheibani N; Maddipati KR
Diabetes; 2011 Feb; 60(2):614-24. PubMed ID: 21228311
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
20. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.
Di Y; Zhang Y; Yang H; Wang A; Chen X
Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
